Astrazeneca reported $10.77B in Sales Revenues for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Abbvie ABBV:US $ 14583M 1045M
Astrazeneca AZN:US $ 10771M 619M
AstraZeneca AZN:LN 10771M 619M
Bristol Myers Squibb BMY:US $ 11887M 239M
Canopy Growth Corp WEED:CN C$ 110.12M 1.66M
Catalent CTLT:US $ 1273M 56M
Corcept Therapeutics CORT:US $ 103.39M 9.7M
Eli Lilly And LLY:US $ 6488M 1322M
Endo International Ordinary Shares ENDP:US $ 569.11M 83.14M
Genmab GEN:DC DK 3162M 1043M
GlaxoSmithKline GSK:LN 6929M 2851M
Horizon Pharma HZNP:US $ 876.41M 8.83M
JAZZ PHA JAZZ:US $ 932.88M 119.16M
Johnson & Johnson JNJ:US $ 24020M 594M
Lannett LCI:US $ 78.36M 8.15M
Merk MRK:US $ 14593M 1308M
Novartis NOVN:VX SF 13085M 271M
Pacira Pharmaceuticals PCRX:US $ 169.41M 11.42M
Perrigo Ordinary Shares PRGO:US $ 1121.7M 47.2M
Pfizer PFE:US $ 27742M 2081M
Phibro Animal Health PAHC:US $ 239.62M 6.91M
Prestige Brands PBH:US $ 277.06M 10.12M
Roche Holding ROG:VX 16.44B 474M
Supernus Pharmaceuticals SUPN:US $ 170.05M 17.55M
Teva Pharmaceutical Industries TEVA:US $ 3786M 125M
Valeant Pharmaceuticals VRX:CN $ 2531.92M 613.92M
Zoetis ZTS:US $ 2052M 66M